Top Markets
Coin of the day
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Peringkat dalam Saham #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Harga Saham
$4.62
Terakhir disinkronkan: 2023-03-23
Kapitalisasi Pasar
$171.76M
Perubahan (1 hari)
-37.16%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan Cellivery Therapeutics, Inc. (268600)

Kategori

Harga 268600 dengan kapitalisasi pasar B
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
268600
$4.62
Kapitalisasi pasar dari Cellivery Therapeutics, Inc.(268600)
Kapitalisasi Pasar: $171.76M
Per August 2026, Cellivery Therapeutics, Inc. memiliki kapitalisasi pasar sebesar $171.76M. Ini menjadikan Cellivery Therapeutics, Inc. sebagai perusahaan 19184th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Cellivery Therapeutics, Inc. dari 2018 hingga 2026
268600 dibandingkan dengan 5 teratas stocks paling populer
Harga 268600 Aset B Pasar B Hasil
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$138,570 $171.76M
$5.152T +2,999,785.97%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$122,018 $171.76M
$4.537T +2,641,448.56%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$112,109 $171.76M
$4.169T +2,426,927.41%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$97,956.71 $171.76M
$3.642T +2,120,552.71%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$75,429.19 $171.76M
$2.805T +1,632,857.36%